» Articles » PMID: 34976869

Harnessing the Potential of MiRNAs in Malaria Diagnostic and Prevention

Overview
Date 2022 Jan 3
PMID 34976869
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Despite encouraging progress over the past decade, malaria remains a major global health challenge. Its severe form accounts for the majority of malaria-related deaths, and early diagnosis is key for a positive outcome. However, this is hindered by the non-specific symptoms caused by malaria, which often overlap with those of other viral, bacterial and parasitic infections. In addition, current tools are unable to detect the nature and degree of vital organ dysfunction associated with severe malaria, as complications develop silently until the effective treatment window is closed. It is therefore crucial to identify cheap and reliable early biomarkers of this wide-spectrum disease. microRNAs (miRNAs), a class of small non-coding RNAs, are rapidly released into the blood circulation upon physiological changes, including infection and organ damage. The present review details our current knowledge of miRNAs as biomarkers of specific organ dysfunction in patients with malaria, and both promising candidates identified by pre-clinical models and important knowledge gaps are highlighted for future evaluation in humans. miRNAs associated with infected vectors are also described, with a view to expandind this rapidly growing field of research to malaria transmission and surveillance.

Citing Articles

Unveiling the therapeutic potential of miR-146a: Targeting innate inflammation in atherosclerosis.

Ardinal A, Wiyono A, Estiko R J Cell Mol Med. 2024; 28(19):e70121.

PMID: 39392102 PMC: 11467738. DOI: 10.1111/jcmm.70121.


Recent advances in the development and clinical application of miRNAs in infectious diseases.

Nunes S, Bastos R, Marinho A, Vieira R, Benicio I, de Noronha M Noncoding RNA Res. 2024; 10:41-54.

PMID: 39296638 PMC: 11406675. DOI: 10.1016/j.ncrna.2024.09.005.


Unravelling the molecular tapestry of pterygium: insights into genes for diagnostic and therapeutic innovations.

Gupta M, Arya S, Agrawal P, Gupta H, Sikka R Eye (Lond). 2024; 38(15):2880-2887.

PMID: 38907016 PMC: 11461965. DOI: 10.1038/s41433-024-03186-y.


Molecular tools are crucial for malaria elimination.

Gupta H, Sharma S, Gilyazova I, Satyamoorthy K Mol Biol Rep. 2024; 51(1):555.

PMID: 38642192 DOI: 10.1007/s11033-024-09496-4.


Starvation induces changes in abundance and small RNA cargo of extracellular vesicles released from Plasmodium falciparum infected red blood cells.

Vetter L, Bajalan A, Ahamed M, Scasso C, Shafeeq S, Andersson B Sci Rep. 2023; 13(1):18423.

PMID: 37891207 PMC: 10611735. DOI: 10.1038/s41598-023-45590-6.


References
1.
Gupta H, Afsal M, Shetty S, Satyamoorthy K, Umakanth S . Plasmodium vivax infection causes acute respiratory distress syndrome: a case report. J Infect Dev Ctries. 2015; 9(8):910-3. DOI: 10.3855/jidc.6813. View

2.
Turner L, Lavstsen T, Berger S, Wang C, Petersen J, Avril M . Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature. 2013; 498(7455):502-5. PMC: 3870021. DOI: 10.1038/nature12216. View

3.
Tjitra E, Anstey N, Sugiarto P, Warikar N, Kenangalem E, Karyana M . Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008; 5(6):e128. PMC: 2429950. DOI: 10.1371/journal.pmed.0050128. View

4.
El Andaloussi S, Mager I, Breakefield X, Wood M . Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013; 12(5):347-57. DOI: 10.1038/nrd3978. View

5.
Wirtz R, Burkot T, Graves P, Andre R . Field evaluation of enzyme-linked immunosorbent assays for Plasmodium falciparum and Plasmodium vivax sporozoites in mosquitoes (Diptera: Culicidae) from Papua New Guinea. J Med Entomol. 1987; 24(4):433-7. DOI: 10.1093/jmedent/24.4.433. View